• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACVRL1 序列变异在遗传性出血性毛细血管扩张症的肝血管畸形中起着关键作用。

Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia.

机构信息

Hospices Civils de Lyon, Service de Génétique, Groupement Hospitalier Est, 69677, Bron, France.

Service de Biostatistique-Bioinformatique, plateforme de séquençage à haut débit, Hospices Civils de Lyon, Lyon, France.

出版信息

Orphanet J Rare Dis. 2020 Sep 22;15(1):254. doi: 10.1186/s13023-020-01533-2.

DOI:10.1186/s13023-020-01533-2
PMID:32962750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7507685/
Abstract

BACKGROUND

Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disorder characterized by multiple telangiectases and caused by germline disease-causing variants in the ENG (HHT1), ACVRL1 (HHT2) and, to a lesser extent MADH4 and GDF2, which encode proteins involved in the TGF-β/BMP9 signaling pathway. Common visceral complications of HHT are caused by pulmonary, cerebral, or hepatic arteriovenous malformations (HAVMs). There is large intrafamilial variability in the severity of visceral involvement, suggesting a role for modifier genes. The objective of the present study was to investigate the potential role of ENG, ACVRL1, and of other candidate genes belonging to the same biological pathway in the development of HAVMs.

METHODS

We selected 354 patients from the French HHT patient database who had one disease causing variant in either ENG or ACVRL1 and who underwent hepatic exploration. We first compared the distribution of the different types of variants with the occurrence of HAVMs. Then, we genotyped 51 Tag-SNPs from the Hap Map database located in 8 genes that encode proteins belonging to the TGF-β/BMP9 pathway (ACVRL1, ENG, GDF2, MADH4, SMAD1, SMAD5, TGFB1, TGFBR1), as well as in two additional candidate genes (PTPN14 and ADAM17). We addressed the question of a possible genetic association with the occurrence of HAVMs.

RESULTS

The proportion of patients with germline ACVRL1 variants and the proportion of women were significantly higher in HHT patients with HAVMs. In the HHT2 group, HAVMs were more frequent in patients with truncating variants. Six SNPs (3 in ACVRL1, 1 in ENG, 1 in SMAD5, and 1 in ADAM17) were significantly associated with HAVMs. After correction for multiple testing, only one remained significantly associated (rs2277383).

CONCLUSIONS

In this large association study, we confirmed the strong relationship between ACVRL1 and the development of HAVMs. Common polymorphisms of ACVRL1 may also play a role in the development of HAVMs, as a modifying factor, independently of the disease-causing variants.

摘要

背景

遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传病,其特征为多发性毛细血管扩张,由 ENG(HHT1)、ACVRL1(HHT2)和在较小程度上 MADH4 和 GDF2 种系致病变异引起,这些基因编码参与 TGF-β/BMP9 信号通路的蛋白。HHT 的常见内脏并发症由肺、脑或肝动静脉畸形(HAVMs)引起。内脏受累的严重程度在家族内存在很大的变异性,提示存在修饰基因的作用。本研究的目的是研究 ENG、ACVRL1 以及属于同一生物学通路的其他候选基因在 HAVMs 发生中的潜在作用。

方法

我们从法国 HHT 患者数据库中选择了 354 名患者,这些患者在 ENG 或 ACVRL1 中均有一种致病变异,并接受了肝脏探查。我们首先比较了不同类型变异的分布与 HAVMs 的发生情况。然后,我们对来自 Hap Map 数据库的 51 个 Tag-SNPs 进行了基因分型,这些 SNPs 位于编码 TGF-β/BMP9 通路蛋白的 8 个基因(ACVRL1、ENG、GDF2、MADH4、SMAD1、SMAD5、TGFB1、TGFBR1)中,以及另外两个候选基因(PTPN14 和 ADAM17)中。我们研究了遗传关联与 HAVMs 发生之间的关系。

结果

携带生殖系 ACVRL1 变异的患者比例和女性比例在有 HAVMs 的 HHT 患者中显著更高。在 HHT2 组中,截断变异的患者 HAVMs 更常见。有 6 个 SNPs(ACVRL1 中的 3 个、ENG 中的 1 个、SMAD5 中的 1 个和 ADAM17 中的 1 个)与 HAVMs 显著相关。在多重检验校正后,只有一个仍然显著相关(rs2277383)。

结论

在这项大型关联研究中,我们证实了 ACVRL1 与 HAVMs 的发生之间的强关系。ACVRL1 的常见多态性也可能作为一个修饰因子,独立于致病变异,在 HAVMs 的发生中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d43/7507685/17e229f83864/13023_2020_1533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d43/7507685/17e229f83864/13023_2020_1533_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d43/7507685/17e229f83864/13023_2020_1533_Fig1_HTML.jpg

相似文献

1
Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia.ACVRL1 序列变异在遗传性出血性毛细血管扩张症的肝血管畸形中起着关键作用。
Orphanet J Rare Dis. 2020 Sep 22;15(1):254. doi: 10.1186/s13023-020-01533-2.
2
The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.ACVRL1基因c.314-35A>G多态性与伴有ENG突变的遗传性出血性毛细血管扩张症患者的器官血管畸形相关,但与伴有ACVRL1突变的患者无关。
Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2.
3
Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.ENG、ACVRL1 和 SMAD4 基因突变与遗传性出血性毛细血管扩张症的临床表现:来自乌普萨拉大学医院奥尔斯勒病中心的经验。
Ups J Med Sci. 2018 Sep;123(3):153-157. doi: 10.1080/03009734.2018.1483452. Epub 2018 Sep 25.
4
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.遗传性出血性毛细血管扩张症:ENG和ALK1突变携带者的临床特征
J Thromb Haemost. 2007 Jun;5(6):1149-57. doi: 10.1111/j.1538-7836.2007.02531.x.
5
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.遗传性出血性毛细血管扩张症的基因型-表型相关性:来自法意遗传性出血性毛细血管扩张症网络的数据。
Genet Med. 2007 Jan;9(1):14-22. doi: 10.1097/gim.0b013e31802d8373.
6
Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症日本患者的突变和临床谱。
BMC Med Genomics. 2021 Dec 6;14(1):288. doi: 10.1186/s12920-021-01139-y.
7
Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.对确诊为遗传性出血性毛细血管扩张症的儿童进行非侵入性CT筛查肺动静脉畸形:两个儿科中心的结果
Pediatr Pulmonol. 2017 May;52(5):642-649. doi: 10.1002/ppul.23649. Epub 2017 Feb 6.
8
Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.挪威遗传性出血性毛细血管扩张症家族的突变分析:ACVRL1中的奠基者突变
Clin Genet. 2016 Feb;89(2):182-6. doi: 10.1111/cge.12612. Epub 2015 Jun 5.
9
Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry.西班牙目前的 HHT 遗传概述及其表型相关性:RiHHTa 注册中心的数据。
Orphanet J Rare Dis. 2020 Jun 5;15(1):138. doi: 10.1186/s13023-020-01422-8.
10
Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.遗传性出血性毛细血管扩张症的基因型-表型相关性:突变与表现
Am J Med Genet A. 2006 Mar 1;140(5):463-70. doi: 10.1002/ajmg.a.31101.

引用本文的文献

1
Hereditary haemorrhagic telangiectasia with atrial septal defect and pulmonary hypertension during advanced pregnancy: a case report and literature review.遗传性出血性毛细血管扩张症伴心房间隔缺损及重度妊娠时肺动脉高压:病例报告及文献复习。
J Int Med Res. 2022 Mar;50(3):3000605221085427. doi: 10.1177/03000605221085427.
2
Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症日本患者的突变和临床谱。
BMC Med Genomics. 2021 Dec 6;14(1):288. doi: 10.1186/s12920-021-01139-y.
3
Investigating the role of imprinted genes in pediatric sporadic brain arteriovenous malformations.

本文引用的文献

1
Gender differences in hereditary hemorrhagic telangiectasia severity.遗传性出血性毛细血管扩张症严重程度的性别差异。
Orphanet J Rare Dis. 2020 Mar 2;15(1):63. doi: 10.1186/s13023-020-1337-5.
2
Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.常见候选变异与遗传性出血性毛细血管扩张症中血管畸形和颅内出血的关联
Mol Genet Genomic Med. 2018 May;6(3):350-356. doi: 10.1002/mgg3.377. Epub 2018 Mar 6.
3
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
研究印记基因在小儿散发性脑动静脉畸形中的作用。
Neural Regen Res. 2022 Jan;17(1):101-102. doi: 10.4103/1673-5374.314296.
胚系 EPHB4 功能丧失性突变导致第二种毛细血管畸形-动静脉畸形(CM-AVM2),该疾病失调 RAS-MAPK 信号通路。
Circulation. 2017 Sep 12;136(11):1037-1048. doi: 10.1161/CIRCULATIONAHA.116.026886. Epub 2017 Jul 7.
4
The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.ACVRL1基因c.314-35A>G多态性与伴有ENG突变的遗传性出血性毛细血管扩张症患者的器官血管畸形相关,但与伴有ACVRL1突变的患者无关。
Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2.
5
Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14.从无病变父母遗传的功能性 ENG 等位基因中的遗传变异与遗传性出血性毛细血管扩张症 1 型(HHT1)中的肺动静脉畸形的存在相关,并且可能影响 PTPN14 的表达。
Front Genet. 2015 Mar 12;6:67. doi: 10.3389/fgene.2015.00067. eCollection 2015.
6
Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era.遗传性出血性毛细血管扩张症:新时代的遗传学与分子诊断
Front Genet. 2015 Jan 26;6:1. doi: 10.3389/fgene.2015.00001. eCollection 2015.
7
Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans.Adam17的基因变异以不同方式调节TGFβ信号通路,从而改变小鼠和人类的血管病理状况。
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7723-8. doi: 10.1073/pnas.1318761111. Epub 2014 May 8.
8
BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia.BMP9 突变导致血管异常综合征,其表型与遗传性出血性毛细血管扩张症重叠。
Am J Hum Genet. 2013 Sep 5;93(3):530-7. doi: 10.1016/j.ajhg.2013.07.004. Epub 2013 Aug 22.
9
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.贝伐珠单抗治疗遗传性出血性毛细血管扩张症伴严重肝血管畸形和高心输出量患者。
JAMA. 2012 Mar 7;307(9):948-55. doi: 10.1001/jama.2012.250.
10
Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia.小鼠和人类策略鉴定 PTPN14 为血管生成和遗传性出血性毛细血管扩张症的修饰因子。
Nat Commun. 2012 Jan 10;3:616. doi: 10.1038/ncomms1633.